These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3777262)

  • 1. Intravenous nicotine in a patient with Alzheimer's disease.
    Newhouse PA; Sunderland T; Thompson K; Tariot PN; Weingartner H; Mueller ER; Cohen RM; Murphy DL
    Am J Psychiatry; 1986 Nov; 143(11):1494-5. PubMed ID: 3777262
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotine therapy in patients with Alzheimer's disease.
    Baldinger SL; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):314-5. PubMed ID: 7606080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nicotine in Alzheimer's disease: a pilot study.
    Newhouse PA; Sunderland T; Tariot PN; Blumhardt CL; Weingartner H; Mellow A; Murphy DL
    Psychopharmacology (Berl); 1988; 95(2):171-5. PubMed ID: 3137593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine and Alzheimer's disease.
    Jones G; Levy R; Sahakian B
    Br J Psychiatry; 1990 Feb; 156():280-1. PubMed ID: 2317633
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotine as a therapeutic drug.
    Westman EC; Levin ED; Rose JE
    N C Med J; 1995 Jan; 56(1):48-51. PubMed ID: 7862206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
    Cosci F; Bertoli G; Abrams K
    Depress Anxiety; 2013 Dec; 30(12):1217-21. PubMed ID: 23554155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine and brain disorders.
    Mihailescu S; Drucker-Colín R
    Acta Pharmacol Sin; 2000 Feb; 21(2):97-104. PubMed ID: 11263271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M
    Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
    Asthana S; Greig NH; Holloway HW; Raffaele KC; Berardi A; Schapiro MB; Rapoport SI; Soncrant TT
    Clin Pharmacol Ther; 1996 Sep; 60(3):276-82. PubMed ID: 8841150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A laboratory procedure for the induction of flashbacks.
    Rainey JM; Aleem A; Ortiz A; Yeragani V; Pohl R; Berchou R
    Am J Psychiatry; 1987 Oct; 144(10):1317-9. PubMed ID: 3661765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of nicotine: addiction and therapeutics.
    Benowitz NL
    Annu Rev Pharmacol Toxicol; 1996; 36():597-613. PubMed ID: 8725403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-smoking as risk factor for Alzheimer's disease?].
    Pfeffer A; Barcikowska M
    Neurol Neurochir Pol; 1998; 32(3):515-21. PubMed ID: 9770689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin replacement therapy for Alzheimer dementia.
    Mouradian MM; Blin J; Giuffra M; Heuser IJ; Baronti F; Ownby J; Chase TN
    Ann Neurol; 1991 Oct; 30(4):610-3. PubMed ID: 1789687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental induction of anxiety. The case of carbon dioxide].
    Griez E
    Encephale; 1987; 13(6):335-9. PubMed ID: 3131110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease. Arresting memory decline.
    Robbins TW
    Nature; 1988 Nov; 336(6196):207-8. PubMed ID: 2848195
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease.
    Alkadhi KA; Srivareerat M; Tran TT
    Mol Cell Neurosci; 2010 Nov; 45(3):289-96. PubMed ID: 20624465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer's disease.
    Raffaele KC; Asthana S; Berardi A; Haxby JV; Morris PP; Schapiro MB; Soncrant TT
    Neuropsychopharmacology; 1996 Aug; 15(2):163-70. PubMed ID: 8840352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine.
    Asthana S; Raffaele KC; Berardi A; Greig NH; Haxby JV; Schapiro MB; Soncrant TT
    Alzheimer Dis Assoc Disord; 1995; 9(4):223-32. PubMed ID: 8749612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.
    Deng J; Shen C; Wang YJ; Zhang M; Li J; Xu ZQ; Gao CY; Fang CQ; Zhou HD
    Eur J Pharmacol; 2010 Jul; 637(1-3):83-8. PubMed ID: 20363218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.